scholarly article | Q13442814 |
P2093 | author name string | Sanjay K Patole | |
Sven M Schulzke | |||
Girish C Deshpande | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | necrotizing enterocolitis | Q10859678 |
systematic review | Q1504425 | ||
P304 | page(s) | 583-590 | |
P577 | publication date | 2007-06-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | JAMA Pediatrics | Q4787306 |
P1476 | title | Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies | |
P478 | volume | 161 |
Q33597728 | Academic, social, and behavioral outcomes at age 12 of infants born preterm |
Q38059806 | An overview of risk factors for poor neurodevelopmental outcome associated with prematurity. |
Q36530748 | Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants |
Q50045044 | Assessing cerebrovascular autoregulation in infants with necrotizing enterocolitis using near-infrared spectroscopy. |
Q88796674 | Association of admission temperature and death or adverse neurodevelopmental outcomes in extremely low-gestational age neonates |
Q35949040 | Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study |
Q90264625 | Born Too Early and Too Small: Higher Order Cognitive Function and Brain at Risk at Ages 8-16 |
Q46848672 | Brainstem auditory response findings in preterm infants after necrotizing enterocolitis |
Q34462269 | Carnitine Deficiency in OCTN2−/− Newborn Mice Leads to a Severe Gut and Immune Phenotype with Widespread Atrophy, Apoptosis and a Pro-Inflammatory Response |
Q102058927 | Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities |
Q40048548 | Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study |
Q35690506 | Cost savings of human milk as a strategy to reduce the incidence of necrotizing enterocolitis in very low birth weight infants. |
Q86689357 | Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet |
Q38198367 | Dual purpose use of preterm piglets as a model of pediatric GI disease |
Q34569160 | Early development of the gut microbiota and immune health |
Q34403042 | Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis |
Q47919617 | Effects of probiotics on experimental necrotizing enterocolitis: a systematic review and meta-analysis |
Q37812528 | Evidence behind the WHO guidelines: Hospital Care for Children: For Young Infants with Suspected Necrotizing Enterocolitis (NEC), What is the Effectiveness of Different Parenteral Antibiotic Regimens in Preventing Progression and Sequelae? |
Q33977758 | Evidence-based guidelines for use of probiotics in preterm neonates |
Q47255608 | Exploring the multiple-hit hypothesis of preterm white matter damage using diffusion MRI. |
Q53754160 | Fast food versus slow food in very and extremely low-birthweight infants: speed of feeds is a little more than a gut feeling. |
Q44193594 | Feeding regimens and necrotising enterocolitis. Concerning the article by C. Maas et Al.: a historic cohort study on accelerated advancement of enteral feeding volumes in very premature infants [Neonatology 2013;103:67-73]. |
Q35744949 | High Risk Infants Follow-Up: A Case Study in Iran |
Q36394014 | Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation |
Q56835398 | IUGR Does Not Predispose to Necrotizing Enterocolitis or Compromise Postnatal Intestinal Adaptation in Preterm Pigs |
Q50523148 | Impact of oral probiotics on neurodevelopmental outcomes in preterm infants |
Q51888821 | Indomethacin Tocolysis and Neurodevelopmental Outcome |
Q37364435 | Infant pain management: a developmental neurobiological approach. |
Q38188656 | Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis |
Q87043668 | Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis |
Q93035715 | Lactoferrin infant feeding trial_Canada (LIFT_Canada): protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infants |
Q34958713 | Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid |
Q30386333 | Long-term outcome of surgically managed necrotizing enterocolitis in a developing country. |
Q38969590 | Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis |
Q37193195 | Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study |
Q43508695 | Necrotizing Enterocolitis in Preterm Infants |
Q93030661 | Necrotizing Enterocolitis, Gut Microbiota, and Brain Development: Role of the Brain-Gut Axis |
Q38024410 | Necrotizing Enterocolitis: Old Problem with New Hope |
Q40553644 | Necrotizing enterocolitis in premature infants and newborns |
Q37138087 | Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation |
Q28079458 | Necrotizing enterocolitis: new insights into pathogenesis and mechanisms |
Q27002820 | Neonatal pain |
Q34185611 | Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia |
Q37204944 | Neurodevelopmental outcome of extremely low birth weight infants with Candida infection |
Q34075235 | Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial |
Q37423356 | Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. |
Q38950327 | Neurofunctional assessment at term equivalent age can predict 3-year neurodevelopmental outcomes in very low birth weight infants. |
Q38012671 | Novel Treatments for NEC: Keeping IBD in Mind |
Q64969749 | Para-probiotics for Preterm Neonates-The Next Frontier. |
Q39059895 | Pathophysiology, prevention, treatment, and outcomes of intestinal failure-associated liver disease |
Q33391658 | Pentoxifylline in preterm neonates: a systematic review |
Q34720825 | Perinatal factors and regional brain volume abnormalities at term in a cohort of extremely low birth weight infants |
Q24236645 | Peritoneal drainage versus laparotomy as initial surgical treatment for perforated necrotizing enterocolitis or spontaneous intestinal perforation in preterm low birth weight infants |
Q38073301 | Physical Therapy Observation and Assessment in the Neonatal Intensive Care Unit |
Q43149673 | Prediction of progression of definite necrotising enterocolitis to need for surgery or death in preterm neonates |
Q35762455 | Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity |
Q37944980 | Probiotics in the Prevention of Necrotizing Enterocolitis |
Q38058122 | Progress in the field of necrotising enterocolitis--year 2012. |
Q57044288 | Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge |
Q39764158 | Risk factors associated with cerebral palsy in preterm infants |
Q33564438 | Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies |
Q47667693 | Risk factors for necrotizing enterocolitis in very preterm infants: a case-control study in southwest China |
Q36496818 | Serum Cytosolic β-Glucosidase Levels In Neonatal Necrotizing Enterocolitis |
Q38867454 | Standardized feeding regimen for reducing necrotizing enterocolitis in preterm infants: an updated systematic review. |
Q36976592 | Stem cells as a potential future treatment of pediatric intestinal disorders |
Q41509354 | Stooling pattern and early nutritional exposures associated with necrotizing enterocolitis in premature infants |
Q38406761 | Surgical necrotizing enterocolitis |
Q38082123 | The Surgical Management of Necrotizing Enterocolitis |
Q37210802 | The immunological landscape in necrotising enterocolitis |
Q37944146 | The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases |
Q38055817 | Treatment of Necrotizing Enterocolitis with Probiotics |
Q24641974 | Update on neonatal anesthetic neurotoxicity: insight into molecular mechanisms and relevance to humans |
Q33998812 | Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis |
Q33693432 | Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection |
Q39042640 | Variability in Antibiotic Regimens for Surgical Necrotizing Enterocolitis Highlights the Need for New Guidelines |
Q38042661 | Which high-risk infants should we follow-up and how should we do it? |
Q48337199 | Withholding Feeds and Transfusion-Associated Necrotizing Enterocolitis in Preterm Infants: A Systematic Review |
Q90676949 | [Long-term prognosis of neonates with necrotizing enterocolitis] |
Search more.